Cardiovascular medication seems to promote recovery of autonomic dysfunction after stroke

Ruihao Wang1, Martin Köhrmann2, Rainer Kollmar1,3

  • 1Department of Neurology, University of Erlangen-Nuremberg, Schwabachanlage 6, 91054, Erlangen, Germany.

Journal of Neurology
|June 11, 2022
PubMed

Insights

Cardiovascular-autonomic modulation (CAM) is compromised after stroke, but typically recovers within 3 months, even with medication. However, some dysfunction persists at 6 months, indicating ongoing autonomic vulnerability.

Area of Science:

  • Neurology
  • Cardiology
  • Autonomic Neuroscience

Background:

  • Stroke can impair cardiovascular-autonomic modulation (CAM).
  • Previous studies on post-stroke CAM alterations excluded patients on cardiovascular medication.
  • This study investigates CAM recovery in patients receiving typical clinical care, including medication.

Purpose of the Study:

  • To evaluate the longitudinal changes in cardiovascular-autonomic modulation (CAM) after ischemic stroke.
  • To determine if CAM dysfunction improves over several months in patients under typical clinical conditions.
  • To assess the impact of cardiovascular medication on CAM recovery post-stroke.

Main Methods:

  • 82 ischemic stroke patients and 30 healthy controls were studied.
  • Cardiovascular medication use before and after stroke was recorded.
  • Autonomic function tests measured parameters of total, sympathetic, and parasympathetic CAM, and baroreflex sensitivity at 1 week, 3 months, and 6 months post-stroke.

Main Results:

  • Stroke patients initially showed impaired CAM and baroreflex sensitivity compared to controls.
  • Significant CAM recovery was observed by 3 months, with some parameters returning to control levels.
  • Despite recovery, some measures of CAM and baroreflex sensitivity remained lower in patients at 6 months.

Conclusions:

  • Even mild ischemic strokes can compromise cardiovagal modulation and baroreflex sensitivity.
  • CAM function largely recovers within 3 months post-stroke, potentially aided by cardiovascular medication.
  • Persistent subtle CAM dysfunction at 6 months suggests continued autonomic vulnerability after stroke.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
527
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
86
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
42
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
40
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
36
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
34